Spectral Med Inc (EDT)

Currency in CAD
1.400
-0.020(-1.41%)
Closed·
EDT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.3901.450
52 wk Range
0.7701.840
Key Statistics
Bid/Ask
1.38 / 1.43
Prev. Close
1.42
Open
1.45
Day's Range
1.39-1.45
52 wk Range
0.77-1.84
Volume
20.43K
Average Volume (3m)
50.45K
1-Year Change
70.7317%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EDT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.150
Upside
+125.00%
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Spectral Med Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.150
(+125.00% Upside)

Earnings

Latest Release
08/05/2026
EPS / Forecast
-0.01 / -0.01
Revenue / Forecast
891K / 754K
EPS Revisions
Last 90 days

Compare EDT to Peers and Sector

Metrics to compare
EDT
Peers
Sector
Relationship
P/E Ratio
−10.8x−2.2x−0.4x
PEG Ratio
0.20−0.080.00
Price/Book
−5.8x1.5x2.6x
Price / LTM Sales
148.8x1.9x3.0x
Upside (Analyst Target)
121.8%33.5%53.2%
Fair Value Upside
Unlock8.7%9.0%Unlock

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

FAQ

What Is the Spectral Med (Toronto: EDT) Share Price Today?

The Spectral Med stock price today is 1.400 CAD.

What Stock Exchange Does Spectral Med (EDT) Trade On?

Spectral Med is listed and trades on the Toronto Stock Exchange.

What Is the Ticker (Stock Symbol) for Spectral Med?

The stock symbol (also called a 'ticker') for Spectral Med is "EDT."

What Is the Current Spectral Med Market Capitalisation?

As of today, Spectral Med (Toronto: EDT) market cap is 410.790M CAD.

What Is Spectral Med's (EDT) Earnings Per Share (TTM)?

The Spectral Med EPS is currently -0.131 (Trailing Twelve Months).

When Is the Next Spectral Med Earnings Date?

Spectral Med's next earnings report will be released on 07/08/2026.

Is EDT a Buy or Sell From a Technical Analyst Perspective?

Based on today's Spectral Med moving averages and other technical indicators, the daily buy/sell signal for EDT stock is Strong Buy.

How Many Times Has Spectral Med Stock Split?

Spectral Med has split 0 times. (See the EDT stock split history page for full effective split date and price information.)

How Many Employees Does Spectral Med Have?

Spectral Med has 29 employees, based on their latest Companies House report.

What is the current trading status of Spectral Med (Toronto: EDT)?

As of 20/07/2026, Spectral Med (EDT) is trading at a share price of 1.400 CAD, with a previous close of 1.420 CAD. The stock has fluctuated within a day range of 1.390 CAD to 1.450 CAD, while its 52-week range spans from 0.770 CAD to 1.840 CAD.

What Is Spectral Med (EDT) Price Target According to Analysts?

The average 12-month price target for Spectral Med is 3.150 CAD, with a high estimate of 3.5 CAD and a low estimate of 2.8 CAD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +125.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.